ReviewCurrent nutrition reports2026
Free Sugars Consumption and Type 2 Diabetes: What Are the Concerns and How Strong is the Evidence?
Review in Current nutrition reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Extension of Added Sugar Use in Packaged Foods Targeted at Children in Brazil.Maternal & child nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThis review examines the relationship between free sugars consumption and type 2 diabetes mellitus (T2DM) risk, with particular focus on the differential effects of sugar types and their delivery forms. Given the unresolved questions and areas of uncertainty in the literature, this analysis aims to clarify the evidence base and inform public health and clinical strategies. RECENT
findingsEpidemiological studies and meta-analyses show inconsistent associations between total sugar intake and T2DM risk. Sugar-sweetened beverages (SSBs), however, are more consistently linked to increased risk, with estimates indicating a 13-30% rise in T2DM risk per daily serving. In contrast, free sugars consumed in solid foods, at typical dietary levels, appear to be effectively metabolized without clear harmful effects for T2DM risks. Experimental evidence indicates that the small intestine plays a key role in metabolizing fructose before it reaches the liver, limiting its contribution to hepatic lipogenesis and associated metabolic disruptions-provided intake remains within normal dietary ranges. Proposed mechanisms for the stronger association with SSBs include faster absorption, minimal satiety response, and reduced dietary compensation, which may contribute to overall excess energy intake. Measurement challenges and heterogeneity across studies complicate interpretation. The form in which sugar is consumed appears more relevant to T2DM risk than the type of sugar itself. Evidence supports focusing public health efforts for T2DM prevention on reducing SSB consumption rather than targeting total free sugar intake. Future research should explore dose-response effects, long-term outcomes, and how individual metabolic profiles interact with different sugar sources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.